Advertisement

Pelvic effusion in patients with ovarian thecoma-fibroma associated with the tumor size and plaste CA-125 level: A retrospective magnetic resonance imaging study

      Highlights

      • This study revealed that the incidence of ascites accompanying thecoma-fibroma was 77.50%.
      • MR images showed tumors could be divide into three types according to the degree of cystic degeneration.
      • This study showed that the incidence of ascites was significantly correlated with tumor size, tumor solidity and serum CA-125 levels.

      Abstract

      Purpose

      To survey the occurrence rate of ascites in patients with thecoma-fibroma and its potential correlation with tumor MR imaging characteristics.

      Methods

      A total of 40 patients with surgically proven thecoma-fibroma were enrolled in this retrospective study. We determined the tumor size, the components (solid or cystic) and their signal intensity features. Second, we identified ascites according to the fat-suppressed sagittal T2-weighted imaging sequence and divided all cases into two groups (with or without ascites). Furthermore, we explored the correlations of ascites with tumor size, tumor solidity, pathological types, patient's postmenopausal status and serum CA-125 levels by using the χ2 test.

      Results

      (1) Among the 40 cases, 15 tumors were fibromas, 15 thecomas, and 10 fibrothecomas. Nine patients (26.47%) had elevated CA-125 levels (>35.0 U/ml). (2) Thirty-one patients had ascites (77.50%), 29 of which had a small amount of ascites. Nine cases had no ascites (22.50%). (3) MRI showed a solid mass in 22 cases (55.0%), cystic mass in five cases (12.5%) and mixed solid-cystic mass in 13 cases (32.5%). The χ2 test revealed that the incidence of ascites was significantly correlated with tumor size, tumor solidity and serum CA-125 levels (P < 0.05), but not with menopause and pathological type (P > 0.05).

      Conclusion

      Our data revealed that the incidence of ascites was 77.50% and was mainly correlated with tumor size and elevated CA-125 levels. These findings have potential value for improving the diagnosis and differential diagnosis of thecoma-fibroma.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Imaging
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Shinagare A.B.
        • Meylaerts L.J.
        • Laury A.R.
        • Mortele K.J.
        MRI features of ovarian fibroma and fibrothecoma with histopathologic correlation.
        AJR Am J Roentgenol. 2012; 198: W296-W303https://doi.org/10.2214/ajr.11.7221
        • Chung B.M.
        • Park S.B.
        • Lee J.B.
        • Park H.J.
        • Kim Y.S.
        • Oh Y.J.
        Magnetic resonance imaging features of ovarian fibroma, fibrothecoma, and thecoma.
        Abdom Imaging. 2015; 40: 1263-1272https://doi.org/10.1007/s00261-014-0257-z
        • Riker D.
        • Goba D.
        Ovarian mass, pleural effusion, and ascites: revisiting Meigs syndrome.
        J Bronchology Interv Pulmonol. 2013; 20: 48-51https://doi.org/10.1097/LBR.0b013e31827ccb35
        • Wu B.
        • Peng W.J.
        • Gu Y.J.
        • Cheng Y.F.
        • Mao J.
        MRI diagnosis of ovarian fibrothecomas: tumour appearances and oestrogenic effect features.
        Br J Radiol. 2014; 8720130634https://doi.org/10.1259/bjr.20130634
        • Zhang H.
        • Zhang H.
        • Gu S.
        • Zhang Y.
        • Liu X.
        • Zhang G.
        MR findings of primary ovarian granulosa cell tumor with focus on the differentiation with other ovarian sex cord-stromal tumors.
        J Ovarian Res. 2018; 11: 46https://doi.org/10.1186/s13048-018-0416-x
        • Zhang Z.
        • Wu Y.
        • Gao J.
        CT diagnosis in the thecoma-fibroma group of the ovarian stromal tumors.
        Cell Biochem Biophys. 2015; 71: 937-943https://doi.org/10.1007/s12013-014-0288-7
        • Takemori M.
        • Nishimura R.
        • Hasegawa K.
        Ovarian thecoma with ascites and high serum levels of CA125.
        Arch Gynecol Obstet. 2000; 264: 42-44https://doi.org/10.1007/pl00007485
        • Chen J.
        • Wang J.
        • Chen X.
        • Wang Y.
        • Wang Z.
        • Li D.
        Computed tomography and magnetic resonance imaging features of ovarian fibrothecoma.
        Oncol Lett. 2017; 14: 1172-1178https://doi.org/10.3892/ol.2017.6228
        • Yang M.
        • Guo S.L.
        • Lei J.Q.
        • et al.
        MRI findings and pathology features of ovarian thecoma.
        Chin J Med Imaging. 2014; 22: 285-288
        • Zhang J.
        • Wang P.
        • Wang G.
        • et al.
        The comparative study of MRI appearances of ovarian thecoma with pathologic findings.
        Chin J Radiol. 2007; 41: 1217-1219
        • Jones O.W.
        • Surwit E.A.
        Meigs syndrome and elevated CA 125.
        Obstet Gynecol. 1989; 73: 520-521
        • Liou J.H.
        • Su T.C.
        • Hsu J.C.
        Meigs&apos; syndrome with elevated serum cancer antigen 125 levels in a case of ovarian sclerosing stromal tumor.
        Taiwan J Obstet Gynecol. 2011; 50: 196-200https://doi.org/10.1016/j.tjog.2011.01.011
        • Amant F.
        • Debiec-Rychter M.
        • Schoenmakers E.F.
        • Hagemeijer-Hausman A.
        • Vergote I.
        Cumulative dosage effect of a RAD51L1/HMGA2 fusion and RAD51L1 loss in a case of pseudo-Meigs&apos; syndrome.
        Genes Chromosomes Cancer. 2001; 32: 324-329https://doi.org/10.1002/gcc.1197
        • Li X.
        • Zhang W.
        • Zhu G.
        • Sun C.
        • Liu Q.
        • Shen Y.
        Imaging features and pathologic characteristics of ovarian thecoma.
        J Comput Assist Tomogr. 2012; 36: 46-53https://doi.org/10.1097/RCT.0b013e31823f6186
        • Tanaka Y.O.
        • Tsunoda H.
        • Kitagawa Y.
        • Ueno T.
        • Yoshikawa H.
        • Saida Y.
        Functioning ovarian tumors: direct and indirect findings at MR imaging.
        Radiographics. 2004; 24: S147-S166https://doi.org/10.1148/rg.24si045501
        • Santangelo M.
        • Battaglia M.
        • Vescio G.
        • et al.
        Meigs&apos; syndrome: its clinical picture and treatment.
        Ann Ital Chir. 2000; 71: 115-119